BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2233517)

  • 1. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma.
    Mandell L; Ghavimi F; LaQuaglia M; Exelby P
    Med Pediatr Oncol; 1990; 18(6):466-71. PubMed ID: 2233517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
    Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
    Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
    J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered.
    Welmant J; Helfre S; Carton M; Bolle S; Minard-Colin V; Corradini N; Pannier S; Rome A; Mansuy L; Vérité C; Castex MP; Kerr C; Defachelles AS; Bernier V; Orbach D
    Strahlenther Onkol; 2021 Aug; 197(8):690-699. PubMed ID: 33914102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
    Ben-Arush M; Minard-Colin V; Scarzello G; Fajardo RD; Terwisscha Van Scheltinga S; Bernier V; Jenney M; Gallego S; Zanetti I; Cesen M; Merks JHM; Bisogno G
    Eur J Cancer; 2022 Sep; 172():119-129. PubMed ID: 35763871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
    J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcoma: the Stanford experience using a TNM staging system.
    Pedrick TJ; Donaldson SS; Cox RS
    J Clin Oncol; 1986 Mar; 4(3):370-8. PubMed ID: 3950676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
    Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
    J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis in childhood rhabdomyosarcoma of the extremity.
    Ghavimi F; Mandell LR; Heller G; Hajdu SI; Exelby P
    Cancer; 1989 Dec; 64(11):2233-7. PubMed ID: 2804912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: Analysis of the EpSSG RMS 2005 study.
    Terwisscha van Scheltinga CEJ; Wijnen MHWA; Martelli H; Guerin F; Rogers T; Craigie RJ; Burrieza GG; Dall'Igna P; De Corti F; Smeulders N; van Rijn RR; Fajardo RD; Mandeville HC; Zanetti I; Coppadoro B; Minard-Colin V; Jenney M; Bisogno G; van Noesel MM; van der Steeg AFW; Merks JHM
    Eur J Surg Oncol; 2022 Jul; 48(7):1536-1542. PubMed ID: 35307252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
    J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
    Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
    J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.
    La TH; Wolden SL; Rodeberg DA; Hawkins DS; Brown KL; Anderson JR; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1151-7. PubMed ID: 20542386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predictive of mortality in pediatric extremity rhabdomyosarcoma.
    LaQuaglia MP; Ghavimi F; Penenberg D; Mandell LR; Healey JH; Hadju SI; Exelby PR
    J Pediatr Surg; 1990 Feb; 25(2):238-43; discussion 243-4. PubMed ID: 2303993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
    Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
    JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy.
    Mandell L; Ghavimi F; Peretz T; LaQuaglia M; Exelby P
    J Clin Oncol; 1990 Sep; 8(9):1536-42. PubMed ID: 2391558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
    Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.